N L Weir1, B T Steffen1, W Guan2, L M Johnson3, L Djousse4, K J Mukamal5, M Y Tsai6. 1. University of Minnesota, Department of Laboratory Medicine & Pathology, 312 Church St. SE Room 3-110, Minneapolis, MN 55455, USA. 2. University of Minnesota, School of Public Health Biostatistics Division, Minneapolis, MN 55455, USA. 3. University of Utah, Department of Pathology, Salt Lake City, UT 84108, USA. 4. Brigham and Women's Hospital, Department of Medicine Division of Aging, Boston, MA 02115, USA. 5. Beth Israel Deaconess Medical Center, General Medicine, Brookline, MA 02446, USA. 6. University of Minnesota, Department of Laboratory Medicine & Pathology, 312 Church St. SE Room 3-110, Minneapolis, MN 55455, USA. Electronic address: tsaix001@umn.edu.
Abstract
AIM: Determine whether plasma omega-7 vaccenic acid and palmitoleic acid levels are related to homeostasis model of insulin resistance scores and incident type II diabetes, and whether race/ethnicity modifies these associations. METHODS: Plasma phospholipid fatty acids were measured by gas chromatography with flame-ionization detection in Multi-Ethnic Study of Atherosclerosis participants. Linear regression determined associations of vaccenic acid and palmitoleic acid with log-transformed homeostasis model of insulin resistance scores (n=5689), and Cox regression determined associations with incident type II diabetes (n=5413, 660 cases). Race-interactions were tested. RESULTS: Adjusting for typical risk factors, higher levels of plasma vaccenic acid were found to be inversely associated with insulin resistance scores across all four race/ethnicities, and a significant race-interaction was observed between Hispanics and Caucasians (P for interaction=0.03). Vaccenic acid was related to 17%, 32%, and 39% lower risks of incident type II diabetes in Black, Hispanic, and Chinese American participants, respectively. Differences in associations between races were detected (P for interactions<0.05). By contrast, higher levels of plasma palmitoleic acid were related to greater insulin resistance scores in Blacks (P<0.001) and Hispanics (P<0.001); significant race-based differences between associations were detected (P for interactions<0.05). Palmitoleic acid was correspondingly related to a 21% greater risk of incident type II diabetes in Black individuals. CONCLUSIONS: Results suggest that plasma vaccenic acid and palmitoleic acid are markers of metabolic health and dysfunction, respectively. Coupled with previous evidence and the significant race-interactions, our findings have implications for future studies of the race-based differences in omega-7 fatty acids and their regulation in the context of deteriorating metabolic health.
AIM: Determine whether plasma omega-7 vaccenic acid and palmitoleic acid levels are related to homeostasis model of insulin resistance scores and incident type II diabetes, and whether race/ethnicity modifies these associations. METHODS: Plasma phospholipid fatty acids were measured by gas chromatography with flame-ionization detection in Multi-Ethnic Study of Atherosclerosis participants. Linear regression determined associations of vaccenic acid and palmitoleic acid with log-transformed homeostasis model of insulin resistance scores (n=5689), and Cox regression determined associations with incident type II diabetes (n=5413, 660 cases). Race-interactions were tested. RESULTS: Adjusting for typical risk factors, higher levels of plasma vaccenic acid were found to be inversely associated with insulin resistance scores across all four race/ethnicities, and a significant race-interaction was observed between Hispanics and Caucasians (P for interaction=0.03). Vaccenic acid was related to 17%, 32%, and 39% lower risks of incident type II diabetes in Black, Hispanic, and Chinese American participants, respectively. Differences in associations between races were detected (P for interactions<0.05). By contrast, higher levels of plasma palmitoleic acid were related to greater insulin resistance scores in Blacks (P<0.001) and Hispanics (P<0.001); significant race-based differences between associations were detected (P for interactions<0.05). Palmitoleic acid was correspondingly related to a 21% greater risk of incident type II diabetes in Black individuals. CONCLUSIONS: Results suggest that plasma vaccenic acid and palmitoleic acid are markers of metabolic health and dysfunction, respectively. Coupled with previous evidence and the significant race-interactions, our findings have implications for future studies of the race-based differences in omega-7 fatty acids and their regulation in the context of deteriorating metabolic health.
Authors: Haiming Cao; Kristin Gerhold; Jared R Mayers; Michelle M Wiest; Steven M Watkins; Gökhan S Hotamisligil Journal: Cell Date: 2008-09-19 Impact factor: 41.582
Authors: Pinal S Patel; Stephen J Sharp; Eugene Jansen; Robert N Luben; Kay-Tee Khaw; Nicholas J Wareham; Nita G Forouhi Journal: Am J Clin Nutr Date: 2010-09-22 Impact factor: 7.045
Authors: Wenjie Ma; Jason H Y Wu; Qianyi Wang; Rozenn N Lemaitre; Kenneth J Mukamal; Luc Djoussé; Irena B King; Xiaoling Song; Mary L Biggs; Joseph A Delaney; Jorge R Kizer; David S Siscovick; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2014-11-12 Impact factor: 7.045
Authors: Lu-Te Chuang; Robert H Glew; Chia-Chun Li; Dorothy J VanderJagt; Julie S Broyles; Gretchen M Ray; Vallabh O Shah Journal: J Diabetes Mellitus Date: 2012-11
Authors: Luke W Johnston; Stewart B Harris; Ravi Retnakaran; Bernard Zinman; Adria Giacca; Zhen Liu; Richard P Bazinet; Anthony J Hanley Journal: J Clin Endocrinol Metab Date: 2016-05-04 Impact factor: 5.958
Authors: Allison M Hodge; Dallas R English; Kerin O'Dea; Andrew J Sinclair; Maria Makrides; Robert A Gibson; Graham G Giles Journal: Am J Clin Nutr Date: 2007-07 Impact factor: 7.045